Rebecca Sarah Tooze

Ms. Rebecca Sarah Tooze

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023 in Genetics in Medicine
Verified
Journal Article
Open access
RTRebecca Sarah Tooze
Rebecca Sarah Tooze
KMKerry A. Miller
Kerry A. Miller
SSSigrid M.A. Swagemakers
Sigrid M.A. Swagemakers
ECEduardo Calpena
Eduardo Calpena
SMSimon J. McGowan
Simon J. McGowan
AWAndrew O. M. Wilkie
Andrew O. M. Wilkie
Studies have previously implicated PRRX1 in craniofacial development, including demonstration of murine Prrx1 expression in the preosteogenic cells of the cranial sutures. We investigated the role of heterozygous missense and loss-of-function (LoF) variants in PRRX1 associated with craniosynostosis. Trio-based genome, exome, or targeted sequencing were used to screen PRRX1 in patients with craniosynostosis; immunofluorescence analyses were used to assess nuclear localization of wild-type and mutant proteins. Genome sequencing identified 2 of 9 sporadically affected individuals with syndromic/multisuture craniosynostosis, who were heterozygous for rare/undescribed variants in PRRX1. Exome or targeted sequencing of PRRX1 revealed a further 9 of 1449 patients with craniosynostosis harboring deletions or rare heterozygous variants within the homeodomain. By collaboration, 7 additional individuals (4 families) were identified with putatively pathogenic PRRX1 variants. Immunofluorescence analyses showed that missense variants within the PRRX1 homeodomain cause abnormal nuclear localization. Of patients with variants considered likely pathogenic, bicoronal or other multisuture synostosis was present in 11 of 17 cases (65%). Pathogenic variants were inherited from unaffected relatives in many instances, yielding a 12.5% penetrance estimate for craniosynostosis. This work supports a key role for PRRX1 in cranial suture development and shows that haploinsufficiency of PRRX1 is a relatively frequent cause of craniosynostosis.

28 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
RTRebecca Sarah Tooze
Rebecca Sarah Tooze
ECEduardo Calpena
Eduardo Calpena
AWAstrid Weber
Astrid Weber
LWLouise C. Wilson
Louise C. Wilson
STStephen R. F. Twigg
Stephen R. F. Twigg
AWAndrew O. M. Wilkie
Andrew O. M. Wilkie
Craniosynostosis, the premature fusion of the cranial sutures, affects ~1 in 2000 children. Although many patients with a genetically determined cause harbor a variant in one of just seven genes or have a chromosomal abnormality, over 60 genes are known to be recurrently mutated, thus comprising a long tail of rarer diagnoses. Genome sequencing for the diagnosis of rare diseases is increasingly used in clinical settings, but analysis of the data is labor intensive and involves a trade-off between achieving high sensitivity or high precision. PanelApp, a crowd-sourced disease-focused set of gene panels, was designed to enable prioritization of variants in known disease genes for a given pathology, allowing enhanced identification of true-positives. For heterogeneous disorders like craniosynostosis, these panels must be regularly updated to ensure that diagnoses are not being missed. We provide a systematic review of genetic literature on craniosynostosis over the last 5 years, including additional results from resequencing a 42-gene panel in 617 affected individuals. We identify 16 genes (representing a 25% uplift) that should be added to the list of bona fide craniosynostosis disease genes and discuss the insights that these new genes provide into pathophysiological mechanisms of craniosynostosis.

21 December 2022 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
RTRebecca Sarah Tooze
Rebecca Sarah Tooze
ECEduardo Calpena
Eduardo Calpena
STStephen R F Twigg
Stephen R F Twigg
FDFelice D'Arco
Felice D'Arco
TCThe Genomics England Research Consortium
The Genomics England Research Consortium
AWAndrew O. M. Wilkie
Andrew O. M. Wilkie
Introduction: SPRY1 encodes protein sprouty homolog 1 (Spry-1), a negative regulator of receptor tyrosine kinase signalling. Null mutant mice display kidney/urinary tract abnormalities and altered size of the skull; complete loss-of-function of Spry-1 in humans has not been reported. Methods: Analysis of whole-genome sequencing data from individuals with craniosynostosis enrolled in the 100,000 Genomes Project identified a likely pathogenic variant within SPRY1. Reverse-transcriptase PCR and western blot analysis were used to investigate the effect of the variant on SPRY1 mRNA and protein, in lymphoblastoid cell lines from the patient and both parents. Results: A nonsense variant in SPRY1, encoding p.(Leu27*), was confirmed to be heterozygous in the unaffected parents and homozygous in the child. The child’s phenotype, which included sagittal craniosynostosis, subcutaneous cystic lesions overlying the lambdoid sutures, hearing loss associated with bilateral cochlear and vestibular dysplasia and a unilateral renal cyst, overlapped the features reported in Spry1−/− null mice. Functional studies supported escape from nonsense-mediated decay, but western blot analysis demonstrated complete absence of full-length protein in the affected child and a marked reduction in both parents. Conclusion: This is the first report of complete loss of Spry-1 function in humans, associated with abnormalities of the cranial sutures, inner ear, and kidneys.

8 July 2022 in Patterns
Verified
Journal Article
Open access
RTRebecca Sarah Tooze
Rebecca Sarah Tooze
Rebecca Tooze, a PhD student in the Oxford Clinical Genetics’ group, discusses the importance and application for data science in her field. Using bioinformatic approaches, she analyzes whole-genome sequencing data from patients with craniosynostosis. In this paper, she comments on her current research and her opportunity as an editorial intern with Patterns.